Literature DB >> 2433658

Massive hemorrhage complicating age-related macular degeneration. Clinicopathologic correlation and role of anticoagulants.

F el Baba, W H Jarrett, T S Harbin, S L Fine, R G Michels, A P Schachat, W R Green.   

Abstract

Reported are 15 cases of age-related macular degeneration (AMD) complicated by massive subretinal and/or vitreous hemorrhage. Clinicopathologic correlation is presented in four of the seven cases studied histopathologically. Salient histologic findings include: subretinal and subretinal pigment epithelium (sub-RPE) fibrovascular scar in the posterior pole; discontinuities in Bruch's membrane with choroidal neovascularization; extensive hemorrhagic detachment of the RPE and sensory retina; and vitreous hemorrhage. In three cases, a choroidal artery, emerging from breaks in Bruch's membrane, had ruptured walls. The authors have reviewed the previously reported cases of AMD complicated by massive hemorrhage and found that 19% of the patients were taking Coumadin (warfarin) or aspirin treatment when the bleeding occurred. Forty percent had a positive history of systemic hypertension and cardiovascular diseases. Although the occurrence of hypertension is expected in the aged population with AMD, use of anticoagulants or antithrombotics by such patients may predispose them to serious ocular hemorrhagic complications.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2433658     DOI: 10.1016/s0161-6420(86)33540-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  32 in total

1.  Case report: sudden painful blindness. Complication of anticoagulant and antiplatelet therapy in patients with disciform macular degeneration.

Authors:  Y Hod; M Zalish; M Neudorfer; J Peer; O Geyer
Journal:  Can Fam Physician       Date:  2001-06       Impact factor: 3.275

2.  Severe post-laser suprachoroidal haemorrhaging in a diabetic patient receiving anticoagulants.

Authors:  A Mikawa; S Honda; I Sugita; N Okamoto; H Toda
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

3.  [Subretinal co-application of rtPA and bevacizumab for exudative AMD with submacular hemorrhage. Compatibility and clinical long-term results].

Authors:  J Hillenkamp; A Klettner; S Puls; F Treumer; J Roider
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

4.  Vitreous haemorrhage associated with Gingko biloba use in a patient with age related macular disease.

Authors:  O P MacVie; B A Harney
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

5.  Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator.

Authors:  Jost Hillenkamp; Vladimir Surguch; Carsten Framme; Veit-Peter Gabel; Helmut G Sachs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-08-11       Impact factor: 3.117

6.  Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women.

Authors:  William G Christen; Robert J Glynn; Emily Y Chew; Julie E Buring
Journal:  Ophthalmology       Date:  2009-10-07       Impact factor: 12.079

7.  [Massive subretinal hemorrhage and anticoagulants. An unfortunate combination?].

Authors:  C Kuhli-Hattenbach; W Miesbach; I Scharrer; L-O Hattenbach
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

8.  Pars plana vitrectomy with peripheral retinotomy after injection of preoperative intravitreal tissue plasminogen activator: a modified procedure to drain massive subretinal haemorrhage.

Authors:  Y Oshima; M Ohji; Y Tano
Journal:  Br J Ophthalmol       Date:  2006-08-17       Impact factor: 4.638

9.  Visual prognosis of eyes with submacular hemorrhage associated with exudative age-related macular degeneration.

Authors:  Naoko Ueda-Arakawa; Akitaka Tsujikawa; Kenji Yamashiro; Sotaro Ooto; Hiroshi Tamura; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2012-10-04       Impact factor: 2.447

10.  Long-term use of aspirin and age-related macular degeneration.

Authors:  Barbara E K Klein; Kerri P Howard; Ronald E Gangnon; Jennifer O Dreyer; Kristine E Lee; Ronald Klein
Journal:  JAMA       Date:  2012-12-19       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.